Ninety-one percent (10 of 11) of PEComas with TSC1 or TSC2 mutations were pS6+, whereas only 44% (5 of 11) without TSC1 or TSC2 mutations were pS6+ (Fisher's exact P = .06). This evidence concerns the gene TSC2 and neoplasm with perivascular epithelioid cell differentiation.